(DIR) Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
 (HTM) https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
 (DIR) Return to: BRIUMVI (ublituximab)
       *****************************************************
       #Post#: 3335--------------------------------------------------
       Ublituximab "reassuring" as potential relapsing MS the
       rapy
       By: agate Date: June 30, 2021, 6:47 pm
       ---------------------------------------------------------
       From Multiple Sclerosis News Today (June 30, 2021)--"Ublituximab
       'Quite Reassuring' as Potential RMS Therapy, Experts Say":
 (HTM) https://multiplesclerosisnewstoday.com/news-posts/2021/06/30/ublituximab-tg-therpeutics-potential-relapsing-ms-therapy-interview-article/
       #Post#: 3424--------------------------------------------------
       Ublituximab up for FDA approval
       By: agate Date: October 2, 2021, 1:04 am
       ---------------------------------------------------------
       From Multiple Sclerosis News Today (October 1,
       2021)--"Ublituximab, Potential Relapsing MS Therapy, Up for FDA
       Approval":
 (HTM) https://multiplesclerosisnewstoday.com/news-posts/2021/10/01/tg-therapeutics-asks-fda-approval-ublituximab-relapsing-ms/
       #Post#: 3505--------------------------------------------------
       Ublituximab as relapsing MS therapy under FDA review
       By: agate Date: December 23, 2021, 1:29 am
       ---------------------------------------------------------
       More on this, from Multiple Sclerosis News Today (December 15,
       2021)--"Ublituximab as relapsing MS therapy under FDA review":
 (HTM) https://bit.ly/32dLrDm
       #Post#: 3687--------------------------------------------------
       (CMSC) Ubilituximab tied to slowed disease progression in relaps
       ing MS
       By: agate Date: June 18, 2022, 1:19 am
       ---------------------------------------------------------
       From Medscape Today (June 10, 2022)--"Novel drug tied to slowed
       disease progression in relapsing MS":
 (HTM) https://www.medscape.com/viewarticle/975368
       #Post#: 3755--------------------------------------------------
       (Abst.) Ublituximab vs. teriflunomide in relapsing MS
       By: agate Date: August 27, 2022, 1:35 am
       ---------------------------------------------------------
       From PubMed (August 25, 2022), citing a New England Journal of
       Medicine article, "Ublituximab versus teriflunomide in relapsing
       multiple sclerosis":
 (HTM) https://pubmed.ncbi.nlm.nih.gov/36001711/
       #Post#: 3769--------------------------------------------------
       New MS drug shows promise in trial
       By: agate Date: September 9, 2022, 7:14 pm
       ---------------------------------------------------------
       From WebMD (August 22, 2022)--"New MS Treatment Shows Promise in
       Trial":
 (HTM) https://wb.md/3BwD1pu
       *****************************************************